Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Effect of Paracervical Block on Postoperative Pain After vNOTES Uterosacral Ligament Suspension

This study is a prospective, randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effect of paracervical block on early postoperative pain after vaginal natural orifice transluminal endoscopic surgery (vNOTES) uterosacral ligament suspension. Eligible patients undergoing vNOTES uterosacral ligament suspension for benign gynecologic indications will be randomly assigned in a 1:1 ratio to receive either 10 mL of 0.5% bupivacaine or 10 mL of normal saline as a paracervical injection during surgery. The primary outcome is postoperative pain assessed using the Visual Analog Scale (VAS) at 6 hours after surgery. Secondary outcomes include pain scores at multiple time points within 24 hours, total analgesic consumption, length of hospital stay, and patient satisfaction. The study aims to determine whether paracervical block provides clinically meaningful pain reduction in the early postoperative period following vNOTES procedures.

Participants needed: 58
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Erkan GolUpdated: Mar 11, 2026Locations: 1
Eligibility criteria

Female patients aged 18 years or older [+4]

Known allergy or hypersensitivity to bupivacaine or local anesthetic agents [+7]

Status: Recruiting

The Effect of Uterine Manipulator Use During Abdominal Hysterectomy on Postoperative Sexual Function

This prospective, single-center, randomized controlled trial aims to evaluate the effect of uterine manipulator use during total abdominal hysterectomy on postoperative female sexual function at 3 months, assessed by the Female Sexual Function Index (FSFI). Secondary outcomes include operative time, perioperative hemoglobin change, postoperative pain (VAS), hospital stay duration, and 30-day complications.

Participants needed: 60
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Erkan GolUpdated: Mar 3, 2026Locations: 1
Eligibility criteria

Women aged ≥18 years [+4]

Gynecologic malignancy [+3]